Cushman & Wakefield
Cushman & Wakefield's revenue rose 8.9% to $10.3 billion in fiscal 2025. Its operating margin was 4.4%, up from 3.6% a year earlier. Free cash flow was $293 million, up 75.5%. The diluted share count rose 0.8%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2021 to 2025, earnings per share fell 23.3% a year and net income 22.9% a year, as new shares raised the share count by 4% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Cushman & Wakefield yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Cushman & Wakefield's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Cushman & Wakefield's fiscal 2025 free cash flow of $293M, net cash of −$2.0B at December 31, 2025 and 235 million diluted shares, from its filings. The scenarios are fitted to Cushman & Wakefield: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 0.6% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 11%: 9% for a business of moderate risk (Real Estate Services), plus 1 point as a smaller company, worth $2.8B, plus 1 point for unsteady results (a loss in fiscal 2023); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $11.90
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Cushman & Wakefield's earnings per share of $0.30 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 39.7×, the middle of Cushman & Wakefield's own P/E today, its peers' median and its sector's median (Cushman & Wakefield's own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 12%, 11% and 10%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $11.90
- Value at this multiple, against the last close
- —
- Cushman & Wakefield's P/E at the last close
- 39.7×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| CoStar GroupCSGP | $33.70 | $0.18 | 187.2× |
| CompassCOMP | $9.69 | $0.06 | 161.5× |
| Cushman & WakefieldCWK | $11.90 | $0.30 | 39.7× |
| Jones Lang LaSalleJLL | $300.61 | $20.86 | 14.4× |
| Newmark GroupNMRK | $11.34 | $0.80 | 14.2× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 771 | 644 | 768 | 793 | 784 |
| Debt incl. finance leases | 3,258 | 3,256 | 3,286 | 3,072 | 2,780 |
| Net debt (negative means net cash) | 2,487 | 2,611 | 2,519 | 2,279 | 1,996 |
| Net debt to EBITDA | 3.7x | 3.8x | 7.2x | 4.9x | 3.6x |
| Debt to equity | 2.2x | 2.0x | 2.0x | 1.8x | 1.4x |
| Interest coverage | 2.8x | 2.8x | 0.7x | 1.5x | 2.1x |
| Current ratio | 1.2x | 1.2x | 1.2x | 1.1x | 1.1x |
| Quick ratio | 1.2x | 1.2x | 1.2x | 1.1x | 1.1x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Cushman & Wakefield shares on the open market, and 2 insiders sold $988,626.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Nathaniel RobinsonSee Remarks | Sold | 12,500 | $13.39 | $167,375 | Form 4 |
| Aug 13, 2026 | Laurida SayedSee Remarks | Sold | 16,000 | $13.88 | $222,080 | Form 4 |
| Jun 4, 2026 | Nathaniel RobinsonSee Remarks | Sold | 24,828 | $13.25 | $328,971 | Form 4 |
| May 12, 2026 | Nathaniel RobinsonSee Remarks | Sold | 10,000 | $13.52 | $135,200 | Form 4 |
| Mar 3, 2026 | Nathaniel RobinsonSee Remarks | Sold | 10,000 | $13.50 | $135,000 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Pass | Pass |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Pass | Fail | Fail |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 4 of 8 | 6 of 8 | 5 of 8 |
| Accruals ratio | −2.4% | −1.0% | −3.3% |
Compare
Put Cushman & Wakefield side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Cushman & Wakefield | FY25 | 8.9% | 4.4% | 2.9% | 8.8% | 3.6x | 5 | |
| Compass | FY25 | 23.7% | −0.9% | 2.9% | — | — | — | Compare |
| Jones Lang LaSalle | FY25 | 11.4% | 4.2% | — | 11.6% | 0.1x | 8 | Compare |
| Newmark Group | FY25 | 20.3% | 7.1% | 4.3% | 8.6% | 1.1x | 7 | Compare |
| CoStar Group | FY25 | 18.7% | −2.2% | 3.8% | −0.6% | −3.3x | 5 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 6,216 | 6,924 | 8,220 | 8,751 | 7,844 | 9,389 | 10,106 | 9,494 | 9,446 | 10,288 |
| Revenue growth | — | 11.4% | 18.7% | 6.5% | −10.4% | 19.7% | 7.6% | −6.1% | −0.5% | 8.9% |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | −295 | −171 | 13 | 187 | −53 | 497 | 535 | 206 | 339 | 452 |
| Net income | −434 | −221 | −186 | 0 | −220 | 250 | 196 | −35 | 131 | 88 |
| Diluted EPS (US$) | −3.07 | −1.54 | −1.09 | 0.00 | −1.00 | 1.10 | 0.86 | −0.16 | 0.56 | 0.38 |
| Diluted shares (millions) | 141 | 144 | 171 | 224 | 221 | 226 | 228 | 227 | 233 | 235 |
| Cash flow | ||||||||||
| Cash from operations | −335 | 4 | −2 | 269 | −38 | 550 | 49 | 152 | 208 | 340 |
| Capital expenditure | 77 | 129 | 84 | 80 | 41 | 54 | 51 | 51 | 41 | 47 |
| Free cash flow | −412 | −125 | −86 | 189 | −79 | 496 | −2 | 101 | 167 | 293 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 57 | 100 | 36 | 276 | 109 | 7 | 33 | 0 | 0 | 5 |
| Stock-based compensation | 49 | 52 | 82 | 61 | 42 | 58 | 40 | 54 | 36 | 58 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 382 | 406 | 895 | 813 | 1,075 | 771 | 644 | 768 | 793 | 784 |
| Debt incl. finance leases | — | 2,838 | 2,694 | 2,658 | 3,272 | 3,258 | 3,256 | 3,286 | 3,072 | 2,780 |
| Total assets | — | 5,793 | 6,546 | 7,163 | 7,338 | 7,890 | 7,949 | 7,774 | 7,549 | 7,677 |
| Total liabilities | — | 5,294 | 5,186 | 5,862 | 6,242 | 6,442 | 6,287 | 6,096 | 5,794 | 5,721 |
| Shareholders' equity | 586 | 499 | 1,360 | 1,301 | 1,095 | 1,448 | 1,661 | 1,677 | 1,755 | 1,955 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| Operating margin | −4.8% | −2.5% | 0.1% | 2.1% | −0.7% | 5.3% | 5.3% | 2.2% | 3.6% | 4.4% |
| Net margin | −7.0% | −3.2% | −2.3% | 0.0% | −2.8% | 2.7% | 1.9% | −0.4% | 1.4% | 0.9% |
| Free cash flow margin | −6.6% | −1.8% | −1.1% | 2.2% | −1.0% | 5.3% | −0.0% | 1.1% | 1.8% | 2.9% |
| Return on capital | — | — | 0.3% | 3.0% | −1.3% | 10.1% | 7.6% | 3.8% | 6.2% | 8.8% |
| Return on equity | — | — | −20.0% | 0.0% | −18.4% | 19.7% | 12.6% | −2.1% | 7.7% | 4.8% |
| Return on assets | — | — | −3.0% | 0.0% | −3.0% | 3.3% | 2.5% | −0.5% | 1.7% | 1.2% |
| Net debt to EBITDA | — | 24.4x | 5.9x | 3.8x | 10.4x | 3.7x | 3.8x | 7.2x | 4.9x | 3.6x |